Cerner (CERN)

In late April, leading supplier of health care information technology, Cerner (NASDAQ:CERN), broke higher on a continuation gap from a powerful bull channel that began in November 2010. We have recommended it many times before and had success each time. On Oct. 21, 2011, at about $66, we said it was a buy with a target of $75, and then on May 21, 2012, it was recommended on a pullback to $75, and it ran to over $88.

The company has exceeded its guidance in 9 of the past 10 quarters, and it again exceeded estimates in Q1, causing a revision of the full year 2013 estimate to $2.80 (up $0.10), and $3.29 in 2014.

CERN is a volatile stock, but that can be used to your advantage. A general market correction or slight earnings miss could cause the stock to fall to under $93, where traders should buy it for a trading target of at least $110. The longer-term objective is $120.